Surgical quality remains a priority for patients with cancer, payers and policymakers. Whether the risk-standardized mortality rate (RSMR) is a better metric than surgical volume to inform the regionalization of cancer surgery remains controversial. In particular, RSMR has been criticized on both theoretical and methodological grounds. Novel alternative means that incorporate surgical volume, as well as evidence-based process measures, are needed.

中文翻译：

---

风险调整体积作为外科肿瘤学的质量指标：一个值得重新审视的观点

手术质量仍然是癌症患者、付款人和政策制定者的首要任务。风险标准化死亡率 (RSMR) 是否是比手术量更好的衡量癌症手术区域化的指标仍然存在争议。特别是，RSMR 在理论和方法上都受到了批评。需要新的替代方法，包括手术量以及基于证据的过程措施。